Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir
- First Online:
- Cite this article as:
- Hussain, S., Khayat, A., Tolaymat, A. et al. Pediatr Nephrol (2006) 21: 1034. doi:10.1007/s00467-006-0109-3
- 96 Views
Tenofovir-related tubule damage characterized by Fanconi syndrome, renal insufficiency and nephrogenic diabetes insipidus has been reported in the adult HIV-infected population. To our knowledge there has been no reported case of such complications in the pediatric population. We report the case of a 12-year-old perinatally HIV-infected African–American girl who developed nephrogenic diabetes insipidus, renal insufficiency and Fanconi-like syndrome while taking tenofovir (Viread) in combination with lopinavir–ritonavir (Kaletra) and didanosine (Videx).